Salivary Gland Carcinoma — Trials

Salivary Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 101–108 of 108 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00085371	Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas	completed	Phase 2	116	National Cancer Institute (NCI)NIH	1	Oct 8, 2013	clinicaltrials
NCT00397787	Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine	completed	Phase 2	64	National Cancer Institute (NCI)NIH	1	Jun 4, 2013